Inhibitory Effect of Myricetin on Matrix Metalloproteinase Expression and Activity in Periodontal Inflammation
4
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Flavonoid myricetin, usually found in tea and medicinal plants, has antioxidant and anti-inflammatory effects. Our objectives in this study were to verify the effects of myricetin on periodontal ligament fibroblasts (PDLFs) under inflammatory conditions and to observe its effects on osteoclast generation and on cytokine expression in RAW264.7 cells. To determine the effects of myricetin on PDLFs, we examined the expression and activity of proteolytic enzymes, including MMP-1, MMP-2, and MMP-8, which all play an important role in chronic periodontitis. We observed the effects of myricetin on intracellular signal transduction to verify the molecular mechanism involved. By measuring the formation of TRAP–positive multinucleated cells and the expression and activity of MMP-8, we were able to assess the effects of myricetin on osteoclast generation. In addition, by measuring the secretion of IL-6 and NO, we could evaluate the effects of myricetin on inflammatory mediators. We found that Myricetin had no effect on the viability of the PDLFs in the presence of inflammation, but it did decrease both the expression of MMP-1 and MMP-8 and the enzyme activity of MMP-2 and MMP-8 in these fibroblasts. Myricetin also decreased the lipopolysaccharide-stimulated phosphorylation of JNK, p38 signaling, IKKB, AKT, and p65RelA in the PDLFs. In the RAW264.7 cells, myricetin inhibited both the expression and the activity of MMP-8. Furthermore, Myricetin not only suppressed the generation of LPS-stimulated osteoclasts, but it also slightly inhibited LPS-stimulated degradation of IkB and decreased the release of LPS-induced IL-6 and NO. These findings suggest that myricetin alleviates the tissue-destructive processes that occur during periodontal inflammation.
Abstract
Flavonoid myricetin, usually found in tea and medicinal plants, has antioxidant and anti-inflammatory effects. Our objectives in this study were to verify the effects of myricetin on periodontal ligament fibroblasts (PDLFs) under inflammatory conditions and to observe its effects on osteoclast generation and on cytokine expression in RAW264.7 cells. To determine the effects of myricetin on PDLFs, we examined the expression and activity of proteolytic enzymes, including MMP-1, MMP-2, and MMP-8, which all play an important role in chronic periodontitis. We observed the effects of myricetin on intracellular signal transduction to verify the molecular mechanism involved. By measuring the formation of TRAP–positive multinucleated cells and the expression and activity of MMP-8, we were able to assess the effects of myricetin on osteoclast generation. In addition, by measuring the secretion of IL-6 and NO, we could evaluate the effects of myricetin on inflammatory mediators. We found that Myricetin had no effect on the viability of the PDLFs in the presence of inflammation, but it did decrease both the expression of MMP-1 and MMP-8 and the enzyme activity of MMP-2 and MMP-8 in these fibroblasts. Myricetin also decreased the lipopolysaccharide-stimulated phosphorylation of JNK, p38 signaling, IKKB, AKT, and p65RelA in the PDLFs. In the RAW264.7 cells, myricetin inhibited both the expression and the activity of MMP-8. Furthermore, Myricetin not only suppressed the generation of LPS-stimulated osteoclasts, but it also slightly inhibited LPS-stimulated degradation of IkB and decreased the release of LPS-induced IL-6 and NO. These findings suggest that myricetin alleviates the tissue-destructive processes that occur during periodontal inflammation.
참고문헌 (23)
- J. W. Costerton, "Bacterial Biofilms: A Common Cause of Persistent Infections", Science, 284(5418), pp.1318~1322 (1999), American Association for the Advancement of Science (AAAS)[DOI]
- R. C. V. Casarin, "Levels of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, inflammatory cytokines and species-specific immunoglobulin G in generalized aggressive and chronic periodontitis", Journal of Periodontal Research, 45(5), pp.635~642 (2010), Wiley-Blackwell[DOI]
- Diya Zhang, "Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS", Innate Immunity, 14(2), pp.99~107 (2008), SAGE Publications[DOI]
- P. P. C. Souza, "Stimulation of IL-6 Cytokines in Fibroblasts by Toll-like Receptors 2", Journal of Dental Research, 89(8), pp.802~807 (2010), SAGE Publications[DOI]
- Julian M.W. Quinn, "Modulation of osteoclast formation", Biochemical and Biophysical Research Communications, 328(3), pp.739~745 (2005), Elsevier BV[DOI]
- Shamima Islam, "5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-κB activation", Cancer Chemotherapy and Pharmacology, 59(2), pp.227~233 (2006), Springer Nature[DOI]
- Sorsa T, "Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collatenases", Infect Immun, 60, pp.4491~4495 (1992)
- Henning Birkedal-Hansen, "Role of Matrix Metalloproteinases in Human Periodontal Diseases", Journal of Periodontology, 64(5s), pp.474~484 (1993), American Academy of Periodontology (AAP)[DOI]
- Timo Sorsa, "Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation", Annals of Medicine, 38(5), pp.306~321 (2009), Informa UK Limited[DOI]
- Kenichiro Kusano, "Regulation of Matrix Metalloproteinases (MMP-2, -3, -9, and -13) by Interleukin-1 and Interleukin-6 in Mouse Calvaria: Association of MMP Induction with Bone Resorption 1", Endocrinology, 139(3), pp.1338~1345 (1998), The Endocrine Society[DOI]
- Akifumi Mizutani, "Expression of Matrix Metalloproteinases During Ascorbate-Induced Differentiation of Osteoblastic MC3T3-E1 Cells", Journal of Bone and Mineral Research, 16(11), pp.2043~2049 (2001), Wiley-Blackwell[DOI]
- Tuula Ingman, "Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients", Journal of Clinical Periodontology, 23(12), pp.1127~1132 (1996), Wiley-Blackwell[DOI]
- P. N. Moynagh, "The NF- B pathway", Journal of Cell Science, 118(20), pp.4589~4592 (2005), The Company of Biologists[DOI]
- Andreas Lewander, "NF-κB p65 phosphorylated at serine-536 is an independent prognostic factor in Swedish colorectal cancer patients", International Journal of Colorectal Disease, 27(4), pp.447~452 (2012), Springer Nature[DOI]
- Ahmed R. El-Awady, "Periodontal Ligament Fibroblasts Sustain Destructive Immune Modulators of Chronic Periodontitis", Journal of Periodontology, 81(9), pp.1324~1335 (2010), American Academy of Periodontology (AAP)[DOI]
- Tatsuo Suda, "Regulation of Osteoclast Function", Journal of Bone and Mineral Research, 12(6), pp.869~879 (1997), Wiley-Blackwell[DOI]
- Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93, pp.165~176 (1998)
- Darnay BG, "Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase", J Biol Chem, 273, pp.20551~20555 (1998)
- Lee SE, "The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation", Bone, 30, pp.71~77 (2002)
- Kyoung-Youn Han, "Inhibition of osteoclast differentiation and bone resorption by sauchinone", Biochemical Pharmacology, 74(6), pp.911~923 (2007), Elsevier BV[DOI]
- Fortis T, "Flavonoids, dietary derived inhibitors of cell proliferation and in vitro angiogenesis", Cancer Res, 57, pp.2916~2921 (1997)
- Kimura M, "Japanese intake of flavonoids and isoflavonoids from foods", J Epidemiol, 8, pp.168~175 (1998)
- Teissedre PL, "Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines", J Sci Food Agric, 70, pp.55~61 (1996)[DOI]